Results 331 to 340 of about 402,660 (356)
Some of the next articles are maybe not open access.
Abstract This chapter discusses dopaminergic drugs whose pharmacokinetic and pharmacodynamic properties are explained. Dopamine metabolism, inhibiting mechanisms, and enzymes are shown in a diagram. Ergotamine derived and non-ergot dopamine agonist drugs are described.
openaire +1 more source
openaire +1 more source
Direct generation of functional dopaminergic neurons from mouse and human fibroblasts
Nature, 2011Massimiliano Caiazzo +16 more
semanticscholar +1 more source
Mesencephalic and extramesencephalic dopaminergic systems in Parkinson’s disease
Journal of Neural Transmission, 2019Fanni F Geibl +2 more
exaly
Regulation of firing of dopaminergic neurons and control of goal-directed behaviors.
Trends in Neurosciences, 2007A. Grace +3 more
semanticscholar +1 more source
Age-Correlated Loss of Dopaminergic Binding Sites in Human Basal Ganglia
Journal of Neurochemistry, 1982J A Severson +2 more
exaly
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Nature, 1988E. Hirsch, A. Graybiel, Y. Agid
semanticscholar +1 more source

